The approval is based on a multi-center, randomized, double-blind, placebo-controlled phase III clinical study to confirm the efficacy and safety of Stapokibart injection in treatment of patients with ...
Nasal symptoms, airflow and markers of ... elucidated but there remains a need for further research. Treatment of established rhinitis may affect asthma control and could have some impact on ...
For patients with allergic rhinitis, twice-daily azelastine plus fluticasone cut nasal symptoms. Intranasal steroids are the most effective pharmacologic treatment for seasonal allergic rhinitis ...
China NMPA approves Keymed Biosciences’ sNDA for Stapokibart to treat chronic rhinosinusitis with nasal polyposis: Chengdu, China Thursday, December 26, 2024, 18:00 Hrs [IST] Ke ...
Damage to these bones can cause complications. If you break the nasal bones, you should see a doctor for treatment. Nasal Fracture. Medscape. Goldenberg, David, and Bradley J. Goldstein. Handbook of ...
(HKEX: 02162) today announced the National Medical Products Administration (the “NMPA”) of China has recently approved the supplemental New Drug Application (the “sNDA”) of Stapokibart (anti-IL-4Rα ...